Exosomes — tiny vesicles used for cell communication, released from specific activated immune cells called polymorphonuclear leukocytes — can induce chronic obstructive…
Articles by Patricia Inácio, PhD
A Phase 2 clinical trial is enrolling participants to evaluate the safety and efficacy of Verona Pharma’s dry powder…
Two new studies highlight the important role of mucus in cleaning and protecting the lungs, and how its accumulation and impaired…
The benefits of Daliresp (roflumilast), an approved chronic obstructive pulmonary disease therapy, may include an anti-inflammatory effect, with the treatment…
GlaxoSmithKline’s application for approval of mepolizumab as an add-on therapy to reduce exacerbations in patients with chronic obstructive pulmonary disease…
Electronic cigarettes help reduce exacerbations and improve exercise capacity in patients with chronic obstructive pulmonary disease (COPD) who saw…
The surgical removal of tonsils and adenoids, a common procedure in children, has been linked to an increased risk of…
The blood growth factor called granulocyte-colony stimulating factor (G-CSF) underlies airway inflammation and lung tissue destruction in COPD, but also…
The antibiotic dirithromycin (no longer available in the U.S.; sold in other countries under the brand name Dynabac) may…
AstraZeneca’s Daliresp (roflumilast) is now approved at 250 micrograms (mcg) for the first four weeks followed by 500…